Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Revokes Approval Of Avastin For Breast Cancer
Federal agency says the drug did not help patients extend their lives or control the tumor and causes serious side effects.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
